Table 3.
Study Group | Prognostic Factors | HR (95% CI) | p-Value |
---|---|---|---|
Patients with diabetes | miR-134-5p | 1.12 (1.05–1.21) | 0.028 |
hs-CRP | 1.14 (1.01–1.28) | 0.022 | |
prior MI | 8.56 (1.91–38.25) | 0.004 | |
LEAD | 11.98 (2.99–48.0) | <0.001 | |
RAS | 20.24 (2.44–167.5) | 0.005 | |
miR-499-5p | 0.16 (0.02–1.32) | 0.089 | |
miR-133a-3p | 2.12 (0.51–8.91) | 0.302 | |
miR-16-5p | 1.01 (0.99–1.02) | 0.410 | |
miR-208b-3p | 5.91 (0.01–7.93) | 0.314 | |
miR 34a-5p | 0.65 (0.15–2.67) | 0.552 | |
Patients diabetes-free | miR-16-5p | 1.0006 (1.0001–1.0011) | 0.016 |
hypertension | 0.27 (0.07–0.95) | 0.042 | |
miR-208b-3p | 2.82 (0.91–8.71) | 0.071 | |
miR-1-3p | 0.58 (0.06–5.22) | 0.628 | |
Fibrinogen | 0.31 (0.08–1.12) | 0.171 |